Thursday Aug 24, 2023

Mazyar Shadman, MD, MPH, Reports the Latest BTKi News in CLL

Dr. Shadman of the Fred Hutchinson Cancer Center in Seattle rounds up the latest news in chronic lymphocytic leukemia (CLL) from the summer conferences, including updates on novel Bruton tyrosine kinase inhibitor (BTKi) therapies in CLL.

Comments (0)

To leave or reply to comments, please download free Podbean or

No Comments

Copyright 2024 All rights reserved.

Podcast Powered By Podbean

Version: 20240731